1. Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009

2. Overview Three-year strategy (2010–2012) will be implemented through three annual work plans, 2010 WP is the first Heart of the agency work remains: State-of-the-art review of the drug phenomenon Maintaining online reference point on drugs Providing ongoing support to for implementation and monitoring of the EUAP 2010 highlights: Ensuring data quality and joined analytical approaches Increase transversal work (CUPs) Establishment of EU guidelines framework and standards Improve detection and exchange on emerging trends Improve monitoring of drug supply and supply reduction activities Methodological developments (KIs, pubic expenditures, monitoring responses) Dissemination and valorisation of EMCDDA products and findings

3. WP schematic

4. Main activities

5. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies More efficient data processing Qualitative data in SB State of the art (AR)

6. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies Promote tools and expert network Finalise TDI review Revise mortality cohort protocol Develop alternative estimates of PDU Finalise DRID protocol

7. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies Polydrug use and vulnerable groups Crime and market

8. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies Treatment coverage day Drug consumption estimates Decentralised data system (data lab.) Incidence of drug use

9. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Implementation of EWS Emerging trends Effective implementation of Council decision Develop Forensic network Conceptualisation monitoring internet Strengthen collaboration (Europol, EMEA…)

10. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Availability, accessibility and characteristics of responses Set of response indicators Developmental areas Tools for non- opiates related problems Use and potential of expert ratings Environmental prevention strategies Fine-tune ST public expenditure

11. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Availability, accessibility and characteristics. of responses Set of response indicators Developmental areas Comprehensive model Availability, coverage of interventions Economic analysis of drug markets Better cover treatment in prison

12. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Availability, accessibility and characteristics. of responses Set of response indicators Developmental areas Drug policy harm indexes Alcohol-cannabis interactions Public expenditure focus on prisons Economic modelling

13. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools to assess drug policies Good practices, guidelines and quality standards EU guidelines for evaluation Cost of drug- related treatment Restructure ELDD 1st progress review (EUAP)

14. 2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools to assess drug policies Good practices, guidelines and quality standards Further develop best practices portal: HR Develop and contribute to EU level guidelines and benchmarks

15. Cross-unit projects

16. 2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Further develop and implement treatment data collection strategy Improve estimates of treatment coverage Improve modelling of service provision vs needs

17. 2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Mini conference on price, purity, supply reduction activities, new trends Further deepen collaboration with EUROPOL Expert working group on DSSR Combined price purity indicator

18. 2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Review current data collection Review and relaunch WHO prison databank

19. 2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Audit and review approaches Develop proposal for scientific monograph

20. Main outputs

21. 2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Annual report Statistical bulletin

22. 2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Harm reduction: evidence, impact and challenges

23. 2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Injecting Treatment and care for older drug users Problem (meth)amphetamine use

24. 2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Drug-related infectious diseases protocol Joint manual for drug information systems EU evidence-based standards for drug prevention

25. 2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles EU’s information needs for effective drug policies Current issues for harm reduction Policy perspective on the use of internet and drug use

26. 2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles The EU cocaine market The EU ecstasy market The EU amphetamine market

27. 2010 work programme – main outputs Ongoing improvement of emcdda.europa.eu Ongoing update of Best practice portal European legal database on drugs (ELDD) Country intervention profiles Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles

28. 2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Comparative analysis of HCV trends Drug-related infectious diseases modelling Polydrug use among treated clients Polydrug use among school children Monitoring drug use in prison European drug consumption Incidence of problems drug use Application of illicit drug analysis in the environment Modelling economic impact of economic recession on drug treatment Modelling disorganised crime: cannabis market

29. Questions and discussion…